MoneyWorks4Me

Auro Laboratories - Quaterly Results

16 May 2023 Evaluate
The sales declined to Rs. 135.25 millions for the March 2023 quarter as compared to Rs. 178.84 millions during the corresponding quarter last year.The Total revenue for the quarter ended March 2023 of  Rs. 17.83  millions  grew by 291.01% from Rs. 4.56 millions.Operating profit surged to 29.71 millions from the corresponding previous quarter of 11.84 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 135.25 178.84 -24.37 528.94 508.66 3.99 528.94 508.66 3.99
Other Income 6.19 2.82 119.50 9.41 10.92 -13.83 9.41 10.92 -13.83
PBIDT 29.71 11.84 150.93 53.33 57.17 -6.72 53.33 57.17 -6.72
Interest 1.34 3.96 -66.16 8.14 8.26 -1.45 8.14 8.26 -1.45
PBDT 28.37 7.88 260.03 45.19 48.91 -7.61 45.19 48.91 -7.61
Depreciation 3.04 2.37 28.27 10.74 10.17 5.60 10.74 10.17 5.60
PBT 25.33 5.51 359.71 34.45 38.74 -11.07 34.45 38.74 -11.07
TAX 7.50 0.95 689.47 10.04 10.29 -2.43 10.04 10.29 -2.43
Deferred Tax 0.03 -0.38 -107.89 0.03 -0.38 -107.89 0.03 -0.38 -107.89
PAT 17.83 4.56 291.01 24.41 28.45 -14.20 24.41 28.45 -14.20
Equity 62.33 62.33 0.00 62.33 62.32 0.02 62.33 62.32 0.02
PBIDTM(%) 21.97 6.62 231.80 10.08 11.24 -10.29 10.08 11.24 -10.29
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..